相关实验视频

Updated: Jun 28, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

基古本囊通过改善线粒体功能障碍来缓解OVA诱导的喘

Xiaoting Ren¹, Yibu Kong², Hongjun Yu²

¹College of Traditional Chinese Medicine, Changchun University of Chinese Medical, Changchun, China.

The Journal of asthma : official journal of the Association for the Care of Asthma

|April 22, 2024

概括

在喘小鼠模型中,YiQi GuBen囊治疗显著减少了肺组织损伤,改善了线粒体功能障碍. 这种传统中医药增强了线粒体的结构和功能,为喘提供了潜在的治疗方法.

科学领域:

线粒体生物学线粒体生物学
肺部病理学肺部病理学
药理学药理学是指药理学的学科.

背景情况:

喘的特点是呼吸道炎症,通常涉及线粒体功能障碍.
线粒体功能障碍有助于喘的发病,影响细胞能量生产和氧化应激.
传统中医药 (TCM) 配方正在研究其在各种疾病 (包括喘) 中的治疗潜力.

研究的目的:

在喘小鼠模型中研究YiQi GuBen囊在改善线粒体功能障碍方面的疗效.
评估YiQi GuBen囊对卵胺诱导喘肺组织病理和线粒体超结构的影响.

主要方法:

建立一个卵泡胺 (OVA) 诱导的喘小鼠模型.
治疗组包括对照组,OVA,德克萨米他 (OVA+DEX) 和YiQi GuBen囊 (OVA+YQGB).
组织病理学分析 (HE和马森染色),传输电子显微镜 (TEM),流动细胞计 (ROS,膜潜力,线粒体数量),线粒体DNA (mtDNA) 复制数分析,以及用于PGC-1α和TFAM表达的西部涂抹.

主要成果:

药物治疗显著减少了肺组织损伤,改善了线粒体的超结构完整性.
流细胞测量显示,在接受治疗的小鼠中,活性氧物种 (ROS) 水平降低,线粒体数量增加,膜潜力改变.
观察到mtDNA拷贝数增加和PGC-1α和TFAM的表达升高,表明线粒体生物发生和功能得到增强.

结论:

YiQi GuBen囊在改善与喘相关的线粒体功能障碍方面表现出显著的治疗效果.
这些发现表明,在OVA诱导的喘模型中,YiQi GuBen囊可以保护肺组织并恢复线粒体健康.
Qi GuBen囊通过准线粒体功能障碍,代表了一种有前途的治疗药物来治疗喘.

关键词:

Qi GuBen 囊是一种药物.过敏性喘过敏性喘线粒体功能障碍线粒体功能障碍卵性白蛋白 (Ovalbumin) 是一种卵性白蛋白.

更多相关视频

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

相关概念视频

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Asthma-IV: Nursing Management

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...